Presentation is loading. Please wait.

Presentation is loading. Please wait.

Illustration of a stably tethered structure made by the DNL method.

Published byJarkko Salminen Modified over 5 years ago

Similar presentations

Presentation on theme: "Illustration of a stably tethered structure made by the DNL method."— Presentation transcript:

1 Illustration of a stably tethered structure made by the DNL method.
Illustration of a stably tethered structure made by the DNL method. The α helices involved in the natural binding interaction of PKA (blue) and AKAPs (yellow) provide a preferred linker module for docking two types of entities, A and B, which are further locked by disulfide linkages (shown as interlocking rings). Such multivalent complexes always contain two copies of entity A. Chien-Hsing Chang et al. Clin Cancer Res 2007;13:5586s-5591s ©2007 by American Association for Cancer Research

Download ppt "Illustration of a stably tethered structure made by the DNL method."

Similar presentations

Antigen specific T-cell Peptide MHC complex T-cell receptor HIV specific.

Antigen specific T-cell Peptide MHC complex T-cell receptor HIV specific.
Rearrangements of Gene A and Gene B

Rearrangements of Gene A and Gene B
(A, B) Stereoscopic views of the P3 RNase MRP RNA domain in complex with the RNase MRP/RNase P protein components Pop6 and Pop7. (A, B) Stereoscopic views.

(A, B) Stereoscopic views of the P3 RNase MRP RNA domain in complex with the RNase MRP/RNase P protein components Pop6 and Pop7. (A, B) Stereoscopic views.
Exposing p120 Catenin's Most Intimate Affair

Exposing p120 Catenin's Most Intimate Affair
From Ionic Currents to Molecular Mechanisms

From Ionic Currents to Molecular Mechanisms
Diagrammatic representation of the proposed first three levels of amylopectin (Ap) structure (adapted from Gallant et al., 1997). Diagrammatic representation.

Diagrammatic representation of the proposed first three levels of amylopectin (Ap) structure (adapted from Gallant et al., 1997). Diagrammatic representation.
Volume 18, Issue 2, Pages (February 2010)

Volume 18, Issue 2, Pages (February 2010)
IL32 prompts cell activation and cancer-related pathways.

IL32 prompts cell activation and cancer-related pathways.
Molecular model of the PTH(1–34)•PTHR1 complex.

Molecular model of the PTH(1–34)•PTHR1 complex.
ROC curve for separating advanced stages (advanced BE and EA) versus early stages (BE or BE instability) using total genome-wide LOH [area under the curve.

ROC curve for separating advanced stages (advanced BE and EA) versus early stages (BE or BE instability) using total genome-wide LOH [area under the curve.
Interaction of drug substrates and the AcrB-binding protomer analyzed with Autodock Vina docking software. Interaction of drug substrates and the AcrB-binding.

Interaction of drug substrates and the AcrB-binding protomer analyzed with Autodock Vina docking software. Interaction of drug substrates and the AcrB-binding.
RLR domains and signaling.

RLR domains and signaling.
Springs and zippers: coiled coils in SNARE-mediated membrane fusion

Springs and zippers: coiled coils in SNARE-mediated membrane fusion
Binding mode of indirubin analogs, BIO and I3O, docked on DVL PDZ.

Binding mode of indirubin analogs, BIO and I3O, docked on DVL PDZ.
Stereoimage of three independent docking simulations of the interaction between clopidogrel acyl 1-β-d-glucuronide and the active site of CYP2C8. Stereoimage.

Stereoimage of three independent docking simulations of the interaction between clopidogrel acyl 1-β-d-glucuronide and the active site of CYP2C8. Stereoimage.
The TSDR of ATL cells exhibits Treg-like hypomethylated status or CD4+ conventional T cell–like methylated status. The TSDR of ATL cells exhibits Treg-like.

The TSDR of ATL cells exhibits Treg-like hypomethylated status or CD4+ conventional T cell–like methylated status. The TSDR of ATL cells exhibits Treg-like.
Structural classes of antimicrobial peptides.

Structural classes of antimicrobial peptides.
A, Top inhibitors of Ba/F3 transformed with CD74–ROS1, color coded by clinical development status: FDA-approved (green), phase III (yellow), phase II (blue),

A, Top inhibitors of Ba/F3 transformed with CD74–ROS1, color coded by clinical development status: FDA-approved (green), phase III (yellow), phase II (blue),
Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.

Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.
Protein expression profile in a dasatinib-resistant cell line.

Protein expression profile in a dasatinib-resistant cell line.

Similar presentations

Ads by Google